Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

End-stage dementia patients deserve the same access to palliative care as people with cancer

There is an urgent need to improve end-of-life care for older people in the final stages of dementia, according to an international review published in the May issue of Journal of Clinical Nursing.

12 May 2008

Next U.S. President should establish center focused on development of cures for diseases, opinion piece states

An expansion of health insurance to more U.S. residents -- with "business, patients and government sharing the cost" -- is important, but unless "we find cures, American families will continue to be plagued by costly and debilitating fatal diseases such as cancer, diabetes and Alzheimer's" disease, former Rep. Harold Ford (D-Tenn.), chair of the Democratic Leadership Council, and Al From, founder and CEO of the council, write in a Memphis Commercial Appeal opinion piece.

11 May 2008

Discovery of mechanism of action of antibiotic able to reduce neuronal cell death in brain

Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer's disease, Huntington's disease, epilepsy, stroke, dementia and malignant gliomas.

11 May 2008

New guidelines say botulinum toxin effective for many neurological disorders, but not headache

New guidelines developed by the American Academy of Neurology confirm that the drug botulinum toxin is safe and effective for treating a variety of neurological conditions. Surprisingly, the drug may not be effective for chronic headaches, accrding to Allison Brashear, M.D., professor and chairman of the Department of Neurology at Wake Forest University Baptist Medical Center, who helped develop the guidelines.

9 May 2008

Hopkins researchers discover new link to schizophrenia

Neuroscientists at Johns Hopkins have discovered that mice lacking an enzyme that contributes to Alzheimer disease exhibit a number of schizophrenia-like behaviors. The finding raises the possibility that this enzyme may participate in the development of schizophrenia and related psychiatric disorders and therefore may provide a new target for developing therapies.

8 May 2008

Enkephalin pathway shows potential as new target for Alzheimer's

Alzheimer's disease (AD) is an incurable disease that is increasing in prevalence and will increase even more rapidly as the Baby Boom generation enters the age of highest risk. The available AD drugs are only partially effective in some patients. New strategies are urgently needed.

7 May 2008

Obesity may increase adults' risk for having dementia

Their analysis of published obesity and dementia prospective follow-up studies over the past two decades shows a consistent relationship between the two diseases. The results are published by The International Association for the Study of Obesity in the May, 2008 issue of Obesity Reviews.

7 May 2008

Obesity can increase dementia risk by up to 80 per cent - people who are underweight also face an elevated risk

Being obese can increase the risk of Alzheimer's Disease by as much as 80 per cent, according to a study in the May issue of the UK-based journal Obesity Reviews.

7 May 2008

Patent claims allowed covering Samaritan's Alzheimer's memory recovery drug in Australia

Samaritan Pharmaceuticals, a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, has received notification that the claims in the patent application for "Neuroprotective Spirostenol Pharmaceutical Compositions" covering Caprospinol (SP-233) have been allowed by the Australian Patent Office.

6 May 2008

Location technologies are improving NHS care

Some of the UK's leading experts in location technologies confirmed this week that applications such as RFID in hospitals are already improving the efficiency and quality of patient care. But they also warn that compatibility problems between hardware and software applications, and a lack of joined up thinking from technology companies mean that the NHS is not benefiting as much as it could.

6 May 2008

Ibuprofen found to reduce the risk of Alzheimer's

A large study by scientists in the U.S. has revealed that the long-term use of ibuprofen may reduce the risk of a person developing Alzheimer's disease.

6 May 2008

Prana Biotechnology has discovered novel drug candidates for use in Parkinson's disease

Prana Biotechnology Limited has announced that it has identified novel therapeutic drug candidates from its Parkinson's disease program. Already, a lead candidate drug has demonstrated positive effects in pre-clinical studies, protecting the brain from damage to the substantia nigra, the area of the brain affected in Parkinson's disease.

6 May 2008

Short arms and legs could mean greater dementia risk

People with shorter arms and legs may be at a higher risk for developing dementia later in life compared to people with longer arms and legs, according to a study published in the May 6, 2008, bonus issue of Neurology, the medical journal of the American Academy of Neurology.

5 May 2008

Ibuprofen linked to lower risk of Alzheimer's

Long-term use of ibuprofen and other drugs commonly used for aches and pains was associated with a lower risk of Alzheimer's disease, according to a study published in the May 6, 2008, issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies have shown conflicting results, but this is the longest study of its kind.

5 May 2008

Breakthrough compound could lead to new class of antihypertensive drugs

University of Florida researchers have identified a drug compound that dramatically lowers blood pressure, improves heart function and - in a remarkable finding - prevents damage to the heart and kidneys in rats with persistent hypertension

1 May 2008

Dual treatment of incontinence and dementia associated with functional decline

Older nursing home residents who took medications for dementia and incontinence at the same time had a 50 percent faster decline in function than those who were being treated only for dementia, according to a study from researchers at Wake Forest University School of Medicine and colleagues.

1 May 2008

Alzheimer's disease risk differs between the sexes

The risks of developing Alzheimer's disease differ between the sexes, with stroke in men, and depression in women, critical factors, suggests research published ahead of print in the Journal of Neurology Neurosurgery and Psychiatry.

30 Apr 2008

Dual treatment of incontinence and dementia associated with functional decline

30 Apr 2008

Alzheimer's and diabetes link

Diabetic individuals have a significantly higher risk of developing Alzheimer's disease but the molecular connection between the two remains unexplained. Now, researchers at the Salk Institute for Biological Studies identified the probable molecular basis for the diabetes - Alzheimer's interaction.

30 Apr 2008

New drug discovery tool for Alzheimer's disease

An article published in the April issue of the Journal of Alzheimer's Disease presents a detailed characterization of a new drug discovery tool for Alzheimer's disease.

28 Apr 2008

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

End-stage dementia patients deserve the same access to palliative care as people with cancer

Next U.S. President should establish center focused on development of cures for diseases, opinion piece states

Discovery of mechanism of action of antibiotic able to reduce neuronal cell death in brain

New guidelines say botulinum toxin effective for many neurological disorders, but not headache

Hopkins researchers discover new link to schizophrenia

Enkephalin pathway shows potential as new target for Alzheimer's

Obesity may increase adults' risk for having dementia

Obesity can increase dementia risk by up to 80 per cent - people who are underweight also face an elevated risk

Patent claims allowed covering Samaritan's Alzheimer's memory recovery drug in Australia

Location technologies are improving NHS care

Ibuprofen found to reduce the risk of Alzheimer's

Prana Biotechnology has discovered novel drug candidates for use in Parkinson's disease

Short arms and legs could mean greater dementia risk

Ibuprofen linked to lower risk of Alzheimer's

Breakthrough compound could lead to new class of antihypertensive drugs

Dual treatment of incontinence and dementia associated with functional decline

Alzheimer's disease risk differs between the sexes

Dual treatment of incontinence and dementia associated with functional decline

Alzheimer's and diabetes link

New drug discovery tool for Alzheimer's disease

eBook: Hallmarks of Neurodegeneration eBook

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Hallmarks of Neurodegeneration eBook

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in